EdgeRock Capital’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-252	Closed	-$34.7K	–	214
2024 Q2	$34.7K	Buy	+252	New	+$34.7K	0.03%	135
2024 Q1	–	Sell	-217	Closed	-$30.8K	–	230
2023 Q4	$30.8K	Buy	+217	New	+$30.8K	0.02%	148